Real-world impact of mepolizumab on symptom control and health utility in severe chronic rhinosinusitis with nasal polyps: the RINOSUR 2.0 multicenter cohort study.

Corrales-Millán R, Maza-Solano J, Benito-Navarro JR, García-García V, Gámiz-Maroto MJ, Márquez-Moyano JA, de la Puerta LPS, Caballero-García A, Guillamón-Fernández D, Ortiz-Rueda M, Alonso-Blanco D, Reyes-Tejero IM, Loaiza-Garreton JP, Müller-Locatelli N, Cuvillo-Bernal A

Open source

DOI: 10.1007/s00405-026-10317-6
Published: 2026 Aug
Container: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00405-026-10317-6,
  title = {Real-world impact of mepolizumab on symptom control and health utility in severe chronic rhinosinusitis with nasal polyps: the RINOSUR 2.0 multicenter cohort study.},
  author = {Corrales-Millán R and Maza-Solano J and Benito-Navarro JR and García-García V and Gámiz-Maroto MJ and Márquez-Moyano JA and de la Puerta LPS and Caballero-García A and Guillamón-Fernández D and Ortiz-Rueda M and Alonso-Blanco D and Reyes-Tejero IM and Loaiza-Garreton JP and Müller-Locatelli N and Cuvillo-Bernal A},
  year = {2026},
  journal = {European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery},
  doi = {10.1007/s00405-026-10317-6},
  url = {https://doi.org/10.1007/s00405-026-10317-6}
}

RIS

TY  - JOUR
TI  - Real-world impact of mepolizumab on symptom control and health utility in severe chronic rhinosinusitis with nasal polyps: the RINOSUR 2.0 multicenter cohort study.
AU  - Corrales-Millán R
AU  - Maza-Solano J
AU  - Benito-Navarro JR
AU  - García-García V
AU  - Gámiz-Maroto MJ
AU  - Márquez-Moyano JA
AU  - de la Puerta LPS
AU  - Caballero-García A
AU  - Guillamón-Fernández D
AU  - Ortiz-Rueda M
AU  - Alonso-Blanco D
AU  - Reyes-Tejero IM
AU  - Loaiza-Garreton JP
AU  - Müller-Locatelli N
AU  - Cuvillo-Bernal A
PY  - 2026
JO  - European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
DO  - 10.1007/s00405-026-10317-6
UR  - https://doi.org/10.1007/s00405-026-10317-6
ER  -

APA

R, C., J, M., JR, B., V, G., MJ, G., JA, M., LPS, D. L. P., A, C., D, G., M, O., D, A., IM, R., JP, L., N, M., & A, C. (2026). Real-world impact of mepolizumab on symptom control and health utility in severe chronic rhinosinusitis with nasal polyps: the RINOSUR 2.0 multicenter cohort study.. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. https://doi.org/10.1007/s00405-026-10317-6

Source records

pubmed · retrieved 2026-09-27T15:57:27.264Z
europe-pmc · retrieved 2026-09-27T15:57:27.281Z